The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with first-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs physician’s choice combination chemotherapy (combo CT) by age in pre/perimenopausal patients (pts) with aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of the RIGHT Choice trial.
 
Nagi S. El Saghir
Honoraria - Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche
 
Yoon Sim Yap
Honoraria - AstraZeneca; Eisai; Lilly; MSD; Novartis; Pfizer; Specialised Therapeutics
Consulting or Advisory Role - AstraZeneca; Eisai; Inivata; Lilly; MSD; Novartis; Pfizer
Research Funding - MSD Oncology (Inst)
 
Yesim Eralp
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Hamdy A. Azim
Employment - Innate Pharma (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Novartis; Roche
 
Julie Rihani
No Relationships to Disclose
 
Nikita Volkov
No Relationships to Disclose
 
Shin-Cheh Chen
No Relationships to Disclose
 
Hakan Harputluoglu
No Relationships to Disclose
 
Patrapim Sunpaweravong
No Relationships to Disclose
 
Yuan-Ching Chang
No Relationships to Disclose
 
Teresa Delgar Alfaro
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jiwen Wu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Huilin Hu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Ming Gao
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Yen-Shen Lu
Honoraria - AstraZeneca; Daiichi Sankyo/UCB Japan; Eisai; EuroPharma; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis